Stocks and Investing
Stocks and Investing
Tue, January 24, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrison Maintained (TNYA) at Buy with Decreased Target to $13 on, Jan 24th, 2023
Matthew Harrison of Morgan Stanley, Maintained "Tenaya Therapeutics, Inc." (TNYA) at Buy with Decreased Target from $15 to $13 on, Jan 24th, 2023.
Matthew has made no other calls on TNYA in the last 4 months.
There are 2 other peers that have a rating on TNYA. Out of the 2 peers that are also analyzing TNYA, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Matthew
- Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $28 on, Friday, November 11th, 2022
- Whitney Ijem of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $21 on, Tuesday, November 8th, 2022
Contributing Sources